Maria Fleseriu, M.D., co-authors new set of guidelines for managing pituitary disease during the COVID-19 pandemic.

While describing his work conducting contact tracing during the pandemic, medical student Teva Brender says the experience has helped him appreciate how much a person’s social or economic situation can be impacted by their health.

A new study co-authored by Craig Newgard, M.D., shows that emergency calls for 911 plummeted by more than a quarter nationwide beginning in March.

Research led by Shoukhrat Mitalipov, Ph.D., and OHSU colleagues revealed that a gene-editing technique can lead to widespread and unintended erasure of genetic code similar to the effect that can occur in the offspring of closely related family members.

In a story about promising results in a randomized controlled trial of critically ill patients led by the University of Oxford, Mark Slifka, Ph.D., says, “Unlike many other experimental therapies, when dexamethasone is used at the right time, for the right patient, there is a significant improvement in survival.”

Roger Chou, M.D., is quoted about a study suggesting that millions of COVID-19 cases in the U.S. may have gone undiagnosed in March.

Jennifer Loftis, Ph.D., is quoted in a story about inflammatory molecules, called cytokines, that may contribute to neuropsychiatric impairments caused by COVID-19.

Gopal Allada, M.D., is quoted in a story dispensing the myth that masks cause CO2 poisoning.

New data shows the mask mandate in Oregon could be making a major difference in slowing the spread of COVID-19.

Atul Deodhar, M.D., is quoted in coverage of new treatment for non-radiographic axial spondyloarthritis.